BRAIN Biotech AG/€BNN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About BRAIN Biotech AG
BRAIN Biotech AG is a German biotechnology company specializing in the development of bio-based products and solutions. Its core business revolves around industrial biotechnology, where it provides services such as strain development, enzyme production, and microbiome enhancement. Founded in 1993, the company has cultivated expertise in researching and developing innovative applications for industries including health, nutrition, and the environment. Based in Zwingenberg, Germany, BRAIN Biotech strategically positions itself as a provider of tailor-made biotech solutions that integrate scientific advances with industrial applications. The company differentiates itself through its emphasis on sustainable technologies and collaborative partnerships in various scientific fields.
Ticker
€BNN
Sector
Primary listing
XETRA
Industry
Chemicals
Headquarters
Employees
285
ISIN
DE0005203947
Website
BRAIN Biotech AG Metrics
BasicAdvanced
€41M
-
-€0.63
0.79
-
Price and volume
Market cap
€41M
Beta
0.79
52-week high
€2.31
52-week low
€1.83
Financial strength
Current ratio
1.847
Quick ratio
1.216
Long term debt to equity
61.563
Total debt to equity
63.83
Interest coverage (TTM)
-2.70%
Profitability
EBITDA (TTM)
-6.868
Gross margin (TTM)
54.42%
Net profit margin (TTM)
-25.52%
Operating margin (TTM)
-19.18%
Effective tax rate (TTM)
1.70%
Revenue per employee (TTM)
€190,000
Management effectiveness
Return on assets (TTM)
-8.42%
Return on equity (TTM)
-102.10%
Valuation
Price to revenue (TTM)
0.78
Price to book
6.87
Price to tangible book (TTM)
-5.48
Price to free cash flow (TTM)
-6.063
Free cash flow yield (TTM)
-16.49%
Free cash flow per share (TTM)
-31.50%
Growth
Revenue change (TTM)
-4.89%
Earnings per share change (TTM)
68.96%
3-year revenue growth (CAGR)
6.36%
3-year earnings per share growth (CAGR)
19.21%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BRAIN Biotech AG stock?
BRAIN Biotech AG (BNN) has a market cap of €41M as of July 04, 2025.
What is the P/E ratio for BRAIN Biotech AG stock?
The price to earnings (P/E) ratio for BRAIN Biotech AG (BNN) stock is 0 as of July 04, 2025.
Does BRAIN Biotech AG stock pay dividends?
No, BRAIN Biotech AG (BNN) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next BRAIN Biotech AG dividend payment date?
BRAIN Biotech AG (BNN) stock does not pay dividends to its shareholders.
What is the beta indicator for BRAIN Biotech AG?
BRAIN Biotech AG (BNN) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.